Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?
A Minimally-invasive Blood-derived Biomarker of Oligodendrocyte Cell-loss in Multiple Sclerosis.
Switching or Discontinuing Disease-Modifying Therapies for Multiple Sclerosis.
Rab27b is Involved in Lysosomal Exocytosis and Proteolipid Protein Trafficking in Oligodendrocytes.
Diagnosis and Management of Multiple Sclerosis in Children.
Astrocyte-targeted production of interleukin-6 reduces astroglial and microglial activation in the cuprizone demyelination model: Implications for myelin clearance and oligodendrocyte maturation.
NG2-glia, More Than Progenitor Cells.
Serum concentration of CD40L is elevated in inflammatory demyelinating diseases.
A Rare Cause of Hemifacial Spasm: Papillary Oncocytic Cystadenoma.
Vitamin D and Alzheimer's Disease: Neurocognition to Therapeutics.
Retinal Vascular Fractals Correlate With Early Neurodegeneration in Patients With Type 2 Diabetes Mellitus.
Neonatal Maternal Separation Impairs Prefrontal Cortical Myelination and Cognitive Functions in Rats Through Activation of Wnt Signaling.
Pancolitis a novel early complication of Alemtuzumab for MS treatment.
CONTRIBUTORS.
INNOVATIVE THERAPIES REDEFINE TREATMENT GOALS IN MULTIPLE SCLEROSIS.
[Anti-MOG + neuromyelitis optica spectrum disorders treated with plasmapheresis].
The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashion.
Irgm1 is required for the inflammatory function of M1 macrophage in early experimental autoimmune encephalomyelitis.
A framework for optimal whole-sample histological quantification of neurite orientation dispersion in the human spinal cord.
Counteracting Fatigue in Multiple Sclerosis with Right Parietal Anodal Transcranial Direct Current Stimulation.
Improved treatment satisfaction after switching therapy to rituximab in relapsing-remitting MS.
Gitelman syndrome, familial seizures, and demyelinating neuropathy: Rare association may be due to sodium potassium cotransporter genes.
In Vitro Effects of Sodium Benzoate on Th1/Th2 Deviation in Patients with Multiple Sclerosis.
Uveitis and the Diagnosis of Multiple Sclerosis.
Tumefactive demyelinating brain lesions with multiple closed-ring enhancement in the course of neuromyelitis optica.
Pages
« first
‹ previous
…
780
781
782
783
784
785
786
787
788
…
next ›
last »